EUVIMEDAtklāt EUVIMED
Crossref

Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials

Lina M Montoya iD, Elvin H Geng, Harriet F Adhiambo, Eliud Akama, Starley B Shade, Assurah Elly, Thomas Odeny, Maya L Petersen

Statistics in Medicine · 2026-06 · 45 (13-14)

DOI: 10.1002/sim.70634 ↗

At a glance

Journal article in Statistics in Medicine, published online on 2026-06-10. Written by Lina M Montoya and 7 co-authors. Institution: School of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Major MEDLINE topics: Cost-Effectiveness Analysis, Cost-Benefit Analysis, Randomized Controlled Trials as Topic. 45 references. Funded by: NIMH NIH HHS.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Sequential multiple assignment randomized trials (SMARTs) have grown in popularity in recent years, and many of their study protocols propose conducting a cost‐effectiveness analysis of the adaptive strategies embedded within them. The cost‐effectiveness of these regimes is often proposed to be assessed using incremental cost‐effectiveness ratios (ICERs). In this paper, we present an estimation and inference procedure for such cost‐effectiveness measures for the embedded dynamic treatment regimes within a SMART design. In particular, we describe a targeted maximum likelihood estimator for the ICER of a SMART's embedded regimes with influence curve‐based inference. We illustrate the performance of these methods using simulations. Throughout, we use as illustration a cost‐effectiveness analysis for the Adaptive Strategies for Preventing and Treating Lapses of Retention in HIV Care (ADAPT‐R; NCT02338739) trial, presenting estimated ICERs (with inference) for embedded regimes aimed at increasing HIV care adherence. This manuscript is one of the first to present cost‐effectiveness analysis results from a SMART.

Subjects

MeSH terms (MEDLINE)

Cost-Effectiveness AnalysisCost-Benefit AnalysisRandomized Controlled Trials as TopicHumansHIV InfectionsLikelihood FunctionsComputer SimulationAnti-HIV Agents

Author keywords

cost‐effectiveness analysisincremental cost‐effectiveness ratiosequential multiple assignment randomized trialtargeted maximum likelihood estimation

Substances

Anti-HIV Agents

Authors and institutions

  • School of Data Science and Society, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
  • Department of Child, Family, and Population Health Nursing, University of Washington, Seattle, WA, USA.
  • Department of Global Health, University of Washington, Seattle, WA, USA.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.

ORCID profiles: Lina M Montoya

Funding

  • NIMH NIH HHS

Cite

APA

Montoya, L. M., Geng, E. H., Adhiambo, H. F., Akama, E., Shade, S. B., Elly, A., Odeny, T., & Petersen, M. L. (2026). Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70634

Vancouver

Montoya LM, Geng EH, Adhiambo HF, Akama E, Shade SB, Elly A, et al. Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70634

BibTeX
@article{Montoya2026,
  author = {Montoya, Lina M and Geng, Elvin H and Adhiambo, Harriet F and Akama, Eliud and Shade, Starley B and Elly, Assurah and Odeny, Thomas and Petersen, Maya L},
  title = {Cost‐Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {13-14},
  doi = {10.1002/sim.70634}
}
Start for free →